SPÓŁKA JAWNA
Apteki Puckie Alexis
Apteki Puckie Alexis Spółka z Ograniczoną Odpowiedzialnością Spółka Jawna
SPÓŁKA JAWNA
Apteki Puckie Alexis Spółka z Ograniczoną Odpowiedzialnością Spółka Jawna
Apteki Puckie Alexis Spółka z Ograniczoną Odpowiedzialnością Spółka Jawna (KRS 0000005390, NIP 5870200990) is a Polish company, headquartered in Puck, Pomorskie voivodeship. APTEKI PUCKIE ALEXIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since March 29, 2001.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Founded
March 29, 2001
25 years in operation
Legal form
SPÓŁKA JAWNA
Registry: RejP
Headquarters
PUCK
POMORSKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
N/A
Shareholders
N/A
Board
N/A
Filed years
N/A
Registry entries
48
latest: January 2, 2026
No KPI data - financial statements and valuation are unavailable for this company.
Rate business credibility - Apteki Puckie Alexis.
No ratings

News
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).

News
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
Latest reporting year
2024
Available years
21
Filing entries
0
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
APTEKI PUCKIE ALEXIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ's board has 1 member.
20 historical registry entries for Apteki Puckie Alexis
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Change in Section 1 (basic data)
GD.VIII NS-REJ.KRS/6302/19/559/ADE
Filing documents submitted (2 documents)
Change in Section 1 (basic data)
GD.VIII NS-REJ.KRS/6302/19/559/ADE
Competing companies or those operating in the same market segment as Apteki Puckie Alexis (in Puck, industry: Retail trade).
WEJHEROWO· Retail trade
Revenue 2024: 625.7 M PLN
GDYNIA· Retail trade
Revenue 2023: 271.9 M PLN
GDAŃSK· Retail trade
Revenue 2024: 243.4 M PLN
GDAŃSK· Retail trade
Revenue 2022: 207.1 M PLN
GDAŃSK· Retail trade
Revenue 2024: 181.2 M PLN
WEJHEROWO· Retail trade
Revenue 2024: 143.6 M PLN